ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE<sup>-/-</sup> mice.
Ontology highlight
ABSTRACT: The asialoglycoprotein receptor 1 (ASGR1), a multivalent carbohydrate-binding receptor that primarily is responsible for recognizing and eliminating circulating glycoproteins with exposed galactose (Gal) or N-acetylgalactosamine (GalNAc) as terminal glycan residues, has been implicated in modulating the lipid metabolism and reducing cardiovascular disease burden. In this study, we investigated the impact of ASGR1 deficiency (ASGR1-/-) on atherosclerosis by evaluating its effects on plaque formation, lipid metabolism, circulating immunoinflammatory response, and circulating N-glycome under the hypercholesterolemic condition in ApoE-deficient mice. After 16 weeks of a western-type diet, ApoE-/-/ASGR1-/- mice presented lower plasma cholesterol and triglyceride
SUBMITTER: Svecla M
PROVIDER: S-EPMC11608471 | biostudies-literature | 2024 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA